Sunday - March 22, 2026

Pulmonary Fibrosis Clinical Trial Analysis 2026: 110+ Companies Advancing 140+ Therapies with Breakthrough Clinical Progress, analyses DelveInsight

Pulmonary Fibrosis Pipeline Pulmonary Fibrosis Companies include Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant Therapeutics, GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Endeavor Biomedicines, Syndax Pharmaceuticals, Regend Therapeutics, among others. According to DelveInsight’s latest evaluation, the global Pulmonary Fibrosis pipeline includes … Continue reading

Obsessive Compulsive Disorder Market to Surpass USD 1 Billion by 2034 | 10+ Key Companies Driving Innovation, analyses DelveInsight

Obsessive Compulsive Disorder Market Obsessive Compulsive Disorder (OCD) companies include Biohaven Pharmaceuticals, AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, among others. DelveInsight’s report titled “Obsessive Compulsive Disorder Market Insights, Epidemiology, and … Continue reading

Alcohol Use Disorder Pipeline Report 2026 Highlights 30+ Companies and 30+ Therapies Shaping Future Treatment Trends, analyses DelveInsight

Alcohol Use Disorder Pipeline Alcohol Use Disorder companies include Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others According to DelveInsight’s evaluation, the global Alcohol Use Disorder (AUD) … Continue reading

Hepatocellular Carcinoma Drug Development Landscape Gains Momentum with Over 90 Companies Advancing Innovative Therapies | DelveInsight

Hepatocellular Carcinoma Pipeline Leading Hepatocellular Carcinoma companies involved in this space include Can-Fite BioPharma, Surface Oncology, Novartis Oncology, GlaxoSmithKline, CStone Pharmaceuticals, Chugai Pharmaceutical, and several others. DelveInsight’s latest report, “Hepatocellular Carcinoma Pipeline Insight 2026,” offers an extensive evaluation of the … Continue reading

Esophageal Cancer Clinical Trial Landscape Gains Momentum as 80+ Biopharma Players Advance Next-Generation Therapies | DelveInsight

Esophageal Cancer Clinical Trials Esophageal Cancer Companies include OncoTherapy Science/Shionogi & Co., Oncolys BioPharma, Lyvgen Biopharma, Adlai Nortye Biopharma, NovaRock Biotherapeutics, Genmab, Genentech, Jiangsu Hengrui Medicine, Taiho Pharmaceutical, Mirati Therapeutics, Boehringer Ingelheim, and several others. DelveInsight’s latest report, “Esophageal Cancer … Continue reading

Hemophilia Clinical Development Landscape Strengthens as 80+ Companies Drive Innovation | DelveInsight

Hemophilia Pipeline Prominent Hemophilia companies include Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therapeutics, Freeline Therapeutics, BioMarin Pharmaceutical, Staidson Beijing BioPharmaceuticals, Pfizer, Sangamo Therapeutics, Amunix, Bioverativ, Novo Nordisk, and others.   DelveInsight’s latest report, “Hemophilia Pipeline Insight, 2026” offers a … Continue reading